Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.25
-1.18 (-4.46%)
May 15, 2026, 10:36 AM EDT - Market open
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.4 billion as of May 15, 2026. Its market cap has increased by 244.96% in one year.
Market Cap
1.40B
Enterprise Value
1.17B
1-Year Change
244.96%
Ranking
Category
Stock Price
$25.25
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.40B, an increase of 103.94%. That is a compound annual growth rate of 74.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 1.46B | -26.63% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.51B |
| Immunocore Holdings | 1.49B |
| Bicara Therapeutics | 1.47B |
| UroGen Pharma | 1.45B |
| Precigen | 1.44B |
| KalVista Pharmaceuticals | 1.42B |
| Damora Therapeutics | 1.39B |
| Biohaven | 1.39B |